HomeHBP • TSE
add
Helix Biopharma Corp
Previous close
$2.05
Day range
$1.99 - $2.06
Year range
$0.50 - $5.40
Market cap
153.03M CAD
Avg Volume
13.37K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 958.00K | -81.79% |
Net income | -950.00K | 82.00% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -957.00K | 81.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.00K | -93.99% |
Total assets | 18.80M | 1,162.73% |
Total liabilities | 3.22M | 103.67% |
Total equity | 15.59M | — |
Shares outstanding | 76.38M | — |
Price to book | 9.76 | — |
Return on assets | -24.18% | — |
Return on capital | -32.96% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | -950.00K | 82.00% |
Cash from operations | -649.00K | 13.24% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -1.00K | -100.09% |
Net change in cash | -650.00K | -275.20% |
Free cash flow | -153.88K | -158.15% |
About
Founded
1995
Headquarters
Website
Employees
7
